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1. Introduction
Optical coherence tomography (OCT) is an optical analog of intravascular ultrasound
(IVUS) that allows microscopic visualization of coronary plaque types and intracoronary tis‐
sue. The high-resolution images of OCT produce an intense interest in adopting this imag‐
ing technique for both clinical and research purposes.
In clinical aspects, OCT imaging for undergoing percutaneous coronary intervention (PCI) is
feasible and provides superior resolution of arterial pathology than IVUS. During PCI, OCT
can assess pre-procedural coronary plaque morphology and acute effects of coronary inter‐
vention (dissection, tissue prolapse, thrombi, and incomplete stent apposition (ISA)). More‐
over, OCT provides more useful information to consider PCI strategy, such as distal
protection, optimal stent landing zone.
In research aspects, OCT provides characterization of coronary plaque to assess factors asso‐
ciated with acute coronary syndrome (ACS) and vessel healing process after stent implanta‐
tion. Recent studies have shown that OCT is useful for the assessment of coronary
atherosclerotic plaques (plaque rupture, erosion, thin-cap fibroatheroma (TCFA), and intra‐
coronary thrombi) in patients with ACS. In addition, OCT can detect the proliferation of va‐
sa vasorum and the distribution of macrophages surrounding vulnerable plaques. OCT
provides cardiologists with the tool they need to better understand the pathological condi‐
tion of ACS.
According to vessel healing after stent implantation, OCT can provide stent strut coverage,
ISA, and restenotic tissue characteristics at follow up. Previous OCT studies have shown
that delayed neointimal coverage after drug-eluting stent (DES) implantation vs. bare metal
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stent (BMS) implantation. Pathological studies have indicated that the proportion of delayed
neointimal coverage represents the best morphometric predictor of late stent thrombosis.
Recent OCT studies demonstrate that restenotic tissue characteristics is completely different
between BMS and DES. Therefore, OCT can play an important role to assess the safety pro‐
file of novel DES systems.
Finally, we introduce usefulness of 3-dimensional reconstruction of the OCT images and 1-μm
resolution OCT.
2. Differences between IVUS and OCT
OCT is an optical analog of IVUS, used to examine the coronary arteries. There is a pressing
need for improved characterization of coronary pathology to better recognize the factors as‐
sociated with coronary vessel disease and to guide the selection of better interventional
strategies. The resolution and contrast of OCT is attractive for these applications and suita‐
ble catheters to access the coronary arteries in detail. There are several differences between
IVUS and OCT, as shown in Table 1 [1]. The resolution of OCT (10-20 μm) is 10-fold higher
than that of IVUS (100-150 μm), but the penetration depth is lower with OCT (1-2 mm) than
with IVUS (4-8 mm) [2]. According to other important difference between IVUS and OCT,
the removal of blood is not need for IVUS examination but OCT examination. To examine
coronary arteries, blood must first be removed during an OCT examination because of the
strong attenuation of light by blood [3].
OCT imaging uses an interferometry technique based on time-delay measurements of the
light reflected or backscattered from the tissues [4]. We can use two processing modes used
for intracoronary OCT imaging, the first generation time-domain OCT (TD-OCT) imaging
systems and the more recently available second generation frequency-domain OCT (FD-
OCT) imaging systems [5, 6].
The first-generation OCT (ImageWire and M2/3 OCT system; LightLab Imaging, Inc., West‐
ford, Massachusetts) incorporated both an OCT imaging wire and an over-the-wire occlu‐
sion balloon. To deliver the image wire and remove blood from the target lesion, an over-
the-wire occlusion balloon catheter was used. The OCT imaging procedure started with
advancing a 0.014-inch coronary guide wire distal to the target lesion. The occlusion catheter
is passed along the guide wire through the lesion. After the guide wire and OCT image wire
were exchanged, the occlusion balloon is pulled back proximal to the lesion. Then, ringer’s
solution was continuously flushed at 0.5–0.6 ml/s through the occlusion catheter lumen us‐
ing a power injector, and the balloon was inflated to 0.3–0.5 atm by an inflation device to
block blood flow. When an OCT image well appeared, a motorized pullback was initiated
from the imaging system console. The first-generation OCT was not user-friendly and had
several disadvantages of complex procedure, such as balloon occlusion and relatively short
length of image acquisition due to the limited frame rate. To improve these disadvantage, a
new generation of OCT systems, termed FD-OCT imaging methods, has been developed.
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease144
FD-OCT imaging methods, utilize a light source with variable wavelength that is tuned to
continuously oscillate between 1250 and 1350 nm, a so-called wavelength swept laser, in‐
stead of the broadband light source used in TD-OCT. As a result, FD-OCT system can ena‐
ble faster image acquisition and greater scan depths compared with TD-OCT system.
Intravascular OCT examination has been frustrated by requiring blood removal. However,
FD-OCT system can enable faster image acquisition and greater scan depths compared with
TD-OCT system. As a result, only intermittent injection of transparent fluid through guiding
catheter for a few seconds enables to obtain entire coronary images [6, 7]. FD-OCT system
has been developed (Dragonfly imaging catheter and C7- XR OCT system; LightLab Imag‐
ing, Inc., St Jude Medical,St Paul, Minnesota, USA). Differences between TD- (M3) and FD-
OCT (C7-XR) systems are shown in Table 1 [8]. This advance may provide dramatic
improvements in understanding coronary atherosclerosis and response to intravascular in‐
terventions such as angioplasty and stenting.
3. Clinical applications of OCT imaging
In clinical aspects, OCT imaging for undergoing PCI is feasible and provides superior reso‐
lution of arterial pathology than intravascular ultrasound. During PCI, OCT can assess pre-
procedural coronary plaque morphology.
Regarding to plaque characterization, OCT can differentiate three types of coronary plaques,
such as fibrous, calcified, and lipid-rich. Fibrous plaque is characterized by a homogenous
high signal region with low attenuation, calcified plaque by a well-delineated, low-signal re‐
gion with sharp borders, and lipid-rich plaques as a low-signal region with diffuse borders
[9]. Importantly, a histology-controlled OCT study showed >90% sensitivity and specificity
for detecting lipid-rich plaque in comparisons with pathological specimens. [9, 10]. More‐
over, OCT can recognize vulnerable plaques, such as plaque rupture, erosion, intracoronary
thrombus, TCFA.
Assessment of plaque characteristics before PCI is useful to choose optimal interventional
strategy. Tanaka et al. showed that TCFA was often observed at target lesions of the patients
with no reflow after PCI compared with good reflow (50% versus 16%, P = 0.005). The fre‐
quency of the no reflow phenomenon increased according to the lipid arc assessed by OCT
[11]. When OCT detects lipid-rich plaque and TCFA especially in patients with ACS, we
should consider to use distal protection devices to prevent no-reflow phenomenon.
Another aspect, plaque type at the stent edges has an impact on the occurrence of edge dis‐
sections. Gonzalo et al. showed that presence of edge dissection was significantly more fre‐
quent when the plaque type at the edge was fibrocalcific (43.8%) or lipid rich (37.5%) than
when the plaque was fibrous (10%) [12]. This study demonstrated that complex plaque type
at the stent edge might influence on the presence of edge dissections from OCT observation.
The OCT guide stenting might be a useful assistance to achieve optimal landing zone.
After PCI, OCT can assess acute effects of coronary intervention (dissection, tissue prolapse,
and ISA). Dissection, tissue prolapse, and ISA were observed more often with OCT than
Clinical and Research Applications of Optical Coherence Tomography Imaging in Coronary Artery Disease
http://dx.doi.org/10.5772/54078
145
with IVUS [13, 14]. Coronary dissection is frequently observed at the distal stent edge be‐
cause of the oversized stent diameter or complex types of plaque at the stent edge by OCT.
When there is no limited coronary flow by angiography and adequate area of the true lumen
by OCT, no additional procedure might be necessary for the treatment of coronary dissec‐
tion [15].
There are 2 types of tissue prolapse, plaque prolapse or thrombus prolapse. OCT can distin‐
guish between plaque prolapse and thrombus prolapse. Plaque prolapse is characterized by
smooth surface with no signal attenuation, and thrombus protrusion by irregular surface
with significant signal attenuation. Minor tissue prolapse identified by IVUS was not found
to be associated with angiographic in-stent restenosis [16]. However, the relationship tissue
prolapse identified by OCT and angiographic in-stent restenosis has not been elucidated.
ISA by OCT was identified as clear separation between at least one stent strut and the vessel
wall. To check the stent apposition to the vessel wall, the distance between surface of stent
strut and adjacent inatima border should be measured because of differences of stent and
polymer thickness [8]. Small ISA, which is detected by only OCT but not by IVUS, could dis‐
appear by neointimal growth during follow-up period [15].
4. Research applications of OCT imaging
In research aspects, OCT can provide characterization of coronary plaque to assess factors
associated with ACS and vessel healing process after stent implantation.
The first OCT study to assess in vivo culprit lesion morphology in patients with ACS
showed that higher frequency of TCFA in ACS compared with stable angina pectoris (72%
in acute myocardial infarction (AMI), 50% in unstable angina pectoris, and 20% in stable an‐
gina pectoris; P = 0.012) [2]. Kubo et al. showed superiorities of TD-OCT for the detection of
plaque rupture (73% vs. 40% vs. 43%, P = 0.021), erosion (23% vs. 0% vs. 3%, P = 0.003), and
thrombus (100% vs. 33% vs. 100%, P < 0.001) compared with IVUS and coronary angioscopy
in patients with AMI [17]. The frequency of vulnerable plaque (plaque rupture, erosion, and
thrombus) by detected OCT was similar to that of the pathological reports. As described
above, OCT is more useful to assess atherosclerotic plaque instability compared to other in‐
tracoronary imaging devices.
OCT has been proposed as a high resolution imaging modality that can identify vasa vaso‐
rum as microchannels with tiny black holes (50-100 μm). The proliferation of vasa vasorum
has been identified recently as a common feature of vulnerable plaque [18]. Kitabata et al.
demonstrated increase of microvessels counts in TCFA [19]. An observational study of OCT
revealed that the presence of microvessels in the plaques was also associated with positive
remodeling and elevated high-sensitive C-reactive protein levels [19]. The OCT evaluation
of microvessels counts might be helpful for assessing plaque vulnerability.
Moreover, the other unique aspect of OCT is the detection of macrophages. Degradation of
the fibrous cap matrix by macrophages is associated with atherosclerotic plaque instability
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[20]. Macrophages detected by OCT were observed as a ‘bright spot’, with a high signal var‐
iance from the surrounding tissue. Tearney et al. [21] and MacNeill et al. [16] descried OCT
is capable to evaluate cap macrophage content accurately. High degree of positive correla‐
tion was observed between OCT and histological measurements of macrophage density in
fibrous cap (r < 0.84, P < 0.0001). OCT provided to detect a cap macrophage density > 10%
with 100% sensitivity and specificity [19].
According to vessel  healing after stent implantation, OCT can provide stent strut cover‐
age,  ISA,  and  restenotic  tissue  characteristics  at  follow  up.  Previous  OCT  studies  have
shown  that  delayed  neointimal  coverage  after  DES  implantation  vs.  BMS  implantation
[22]. Pathological studies have indicated that the proportion of delayed neointimal cover‐
age represents  the best  morphometric  predictor  of  late  stent  thrombosis  [23,  24].  Recent
OCT studies demonstrate that  restenotic  tissue characteristics  is  completely different be‐
tween BMS and DES [21,  25].  Therefore,  OCT can play an important  role  to  assess  the
safety profile of novel DES systems.
5. Future directions of OCT imaging
Recently, a second-generation OCT technology, termed FD-OCT, has been developed that
solves the TD-OCT limitations by imaging at much higher frame rates with slightly deeper
penetration depth and greater scan area. In combination with a short, non-occlusive flush
and rapid spiral pullback, the higher frame rates generated by FD-OCT enable imaging of
the 3-dimensional reconstruction of longer segments of coronary arteries. The 3-dimensional
OCT can express all of the coronary microanatomy and pathology previously visualized by
OCT, including lipid pools, calcium, macrophages, thin fibrous caps, cholesterol crystals,
thrombus, stent, and stents with neointimal hyperplasia [26]. The 3-dimensional OCT may
be useful as a research tool for assessing human coronary pathophysiology and as a clinical
tool for guiding the management of coronary artery disease.
Progress in understanding, diagnosis, and treatment of coronary artery disease has been
hindered because of inability to observe cells and extracellular components associated with
human coronary atherosclerosis in situ. A μOCT system with a very broad bandwidth light
source and common-path spectral-domain OCT technology provides 1-μm axial resolution
ranging in tissue [27]. The μOCT is possible to visualize many key cellular and subcellular
features relevant to atherogenesis, plaque rupture, thrombosis, and neointimal healing after
stenting in situ. The μOCT technology has the potential to make a significant impact in car‐
diovascular pathology.
6. Conclusion
The high resolution of OCT provides histology-grade definition of the microstructures of
coronary atherosclerosis in vivo. Introduction of this attractive imaging method contributes
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significant progression in both clinical and research aspects. Clinically, OCT can provide
more useful information to consider PCI strategy for getting the optimal interventional re‐
sults. On the other hand, OCT is a useful imaging device for understanding, diagnosis, and
treatment of coronary artery disease. In the future direction of OCT systems, 3-dimensional
OCT and μOCT may be upcoming in the field of coronary artery disease. These novel OCT
technologies will play an important role for investigation of coronary artery disease.
IVUS TD-OCT (M3) FD-OCT (C7)
Axial resolution, μm 100-150 15-20 12-15
Lateral resolution, μm 150-300 39 19
Frame rate, fps 30 20 100
Pullback speed, mm/s 0.5-2.0 0.5-2.0 10-25
Scan diameter, mm 8-10 6.8 10
Penetration depth, mm 4-8 1-2 1-2
Balloon occlusion Unnecessary Necessary Unnecessary
IVUS, intravascular ultrasound; OCT, optical coherence tomography; TD, time-domain; FD, frequency-domain; fps,
frames per second.
Modified from Terashima M et al, korean j intern med 2012;27:1-12.
Table 1. Differences among IVUS, TD-OCT, and FD-OCT
IVUS OCT
Dissection ○ ◎
Tissue prolapse △ ◎
ISA ○ ◎
Stent expansion ◎ ○
Lesion coverage ○ ○
IVUS, intravascular ultrasound; OCT, optical coherence tomography; ISA, incomplete stent apposition.
Table 2. Acute effects of coronary intervention between IVUS and OCT
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